Who We Are
At Insulin for Life USA, we understand that diabetes is a global problem.
Our Mission and Impact
IFL USA’s mission is simple: to bring the necessary resources
to individuals with diabetes.
We do this by collecting unopened, in-date diabetes supplies from individuals, organizations, and corporations—resources that would often go to waste—and redistributing them through vetted healthcare providers across the U.S. and internationally.
Once these life-sustaining supplies are donated, we handle the rest: inspecting, processing, and shipping them to the communities that need them most. This approach not only addresses critical healthcare gaps but also reduces medical waste by putting already-manufactured goods to life-saving use.
Our work is made possible by the generosity of our partners, the dedication of our passionate board of directors, and the continued support from individuals both within and beyond the diabetes community. Every donation—whether supplies or financial support—helps someone in need gain access to care they might not otherwise receive.
Since 2012, IFL USA has shipped over 260,000 pounds of vital diabetes-management supplies, reaching more than 40,000 people in the Caribbean, Central, North, and South America, as well as Central, East, and West Africa.
In 2024 alone, IFL USA received 4,360 in-kind donations and completed 186 shipments — 76 of them within the U.S. — delivering a total of 18,000 pounds of insulin and diabetes supplies to save lives.
Imagine: 22 million units of insulin, 384,341 test strips, and 11,150 sensors — spared from landfills and transformed into lifelines for hundreds, all in just one year!
Inside Insulin for Life USA
Our Team
Svetlana Hutfles
Executive Director
Svetlana Hutfles brings over two decades of experience in philanthropy, nonprofit leadership, and cross-sector partnerships in the U.S. and internationally. Her career has been dedicated to advancing community health, equity, and sustainable development by strengthening organizations’ capacities, building collaborative networks, and elevating underserved voices. At IFL USA, Svetlana draws on her expertise in strategy, communications, and global development to support systems that deliver life-sustaining care to people with diabetes.
Perfect way to end your day?
Getting enthralled in the art of salsa social dancing — creating a fleeting experience that will never be repeated, much like a Buddhist mandala.
What’s your favorite meal?
Seafood. I’m shellfishly devoted.
What is the most exciting part of working with IFL USA?
Witnessing the quiet power of collective giving — turning donations into lifelines and knowing that every day, we make a real, tangible difference in someone’s story.
Carol Atkinson
Founding Executive Director Emeritus
Our Founding Executive Director Emeritus, Carol, has enjoyed watching IFL USA, Florida grow since she helped found it in 2012. She works closely with the Board of Directors, partners, and supports in guiding the activities of IFL to provide life-sustaining supplies to those in need.
What is your favorite memory from working for Insulin for Life USA?
In September of 2017 receiving a desperate call for supplies in Wharton, Texas. Despite it being a holiday weekend, leaving normal delivery challenges nonoperational, we successfully delivered supplies within 12 hours.
What is your favorite season?
Fall because I love apples, apple cider, and the fall leaves.
Favorite thing about Gainesville?
The influx of new community members driven by the University.
Maggie Angelillo
International Program Specialist
Maggie, from Memphis, TN has a degree in Psychology from the University of Memphis and currently resides in Tuscaloosa, AL. She assists in creating shipments of supplies to our international partners by capturing clinic usage, prepping inventories, and pulling supplies going out. She loves being able to support IFL’s partners in their endeavors to make life with diabetes manageable.
Favorite thing about working for IFL?
Being able to respond quickly to disaster situations both here in the US and around the world.
What are you currently watching?
I’m bouncing between rewatching How I Met Your Mother for the second time and Gilmore Girls for the I’m not sure how many times!
What’s your most used emoji?
🙃
Nathalia Gomes
Outreach & Processing Associate
Nathalia, from São Paulo, Brazil, is on the path to earning a Nutritional Sciences degree from the University of Florida while working with IFL and plans to go to medical school. She works on processing incoming donations and is passionate about making an impact in the community after growing up and seeing the effect it has on people with diabetes and those around them.
What is your favorite pasta shape and why?
Fettuccine because you get the most pasta out of each piece without it being overwhelming.
Have you gotten into any new hobbies recently?
Yes, interior designing.
What is the perfect way to end your day?
Getting cozy and falling asleep while watching a movie without a care in the world.
Hazel Sprigg
Outreach & Processing Associate
Hazel, from San Diego, CA, is a University of Notre Dame graduate with a degree in Computer Science. Hazel is a passionate creative driven by her belief that change is an act of love and dedicated to using her voice and artistry to sculpt the world around her to be more kind, empathetic, diverse, and accessible. Her favorite part of working at IFL is the opportunity to utilize all of her skills, talents, and passion to affect positive change for free and open insulin access to be the basic human right it should be.
What are you currently watching?
Gachiakuta! It’s an anime about the power and impact of treating other people, objects, and the world around us with love and care. I absolutely love both the messaging and the aesthetic!
What’s your most used emoji?
✨
Perfect way to end your day?
Dancing around the kitchen with my partner, Nina, and our cat, Stinky, as we cook something delicious!
Hailey Long
Outreach & Processing Associate
Born and raised in Newberry, FL, Hailey is working towards a degree in Geology at Santa Fe College with the long-term goal of becoming an anthropologist. At IFL, she takes on a variety of tasks, including processing and preparing supplies for shipment to domestic clinics — playing an essential role in getting critical resources to those in need. Her curiosity about the world and care for her community shine through the hands-on work she does every day.
Favorite concert you’ve attended?
Halsey’s 2022 Love and Power tour
Perfect way to end your day?
Relaxing with my friends and pets!
What is your favorite playlist at work?
Anything from Fall Out Boy or Sleep Token
Board Members
MARK ATKINSON, PH.D
President
Dr. Atkinson is currently a Professor of Pathology & Pediatrics and Eminent Scholar for Diabetes Research at The University of Florida, where he also serves as the inaugural Executive Director of the UF Diabetes Institute. The author of over 375 publications, Dr. Atkinson is in his third decade of investigation into the field of type 1 (insulin-dependent) diabetes where he undertakes studies seeking to identify the causes of and a cure for the disease. Dr. Atkinson has been the recipient of multiple scientific and humanitarian-based awards for these efforts. He has also been active in leadership service to the type 1 diabetes community, with administrative or advisory service to The Juvenile Diabetes Research Foundation, The American Diabetes Association, The National Institutes of Health, Diapedia, the Immunology of Diabetes Society, and approximately ten pharmaceutical/biotechnology companies.
Margery Perry
Vice President
Margery Perry has been involved in type 1 diabetes research and advocacy since her daughter Adriana was diagnosed over 26 years ago. She is very active in the diabetes community and has served on multiple non-profit Board of Directors, including the International Board of the JDRF, as the Chair of Research. Margery also served on the National Institutes of Health Advisory Council for the National Institute of Diabetes and Digestive and Kidney Diseases. Margery remains committed to finding a cure for type 1 diabetes and improving the lives of those that have the disease.
Howard Halligan
Secretary & Treasurer
Howard Halligan, a type 1 diabetic since age 12, has been involved in diabetes research projects and charitable activities for decades. Most notable is his participation in the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and Complications (EDIC) study and his work as a board member and treasurer of the Reader’s Digest Foundation, which supports literacy and education organizations, with an emphasis on employees’ charitable efforts. Professionally, Howard most recently served as chief financial officer and chief operating officer of Trusted Media Brands, Inc., where he collaborated on a myriad of successful initiatives, including the successful launches of the magazine, Every Day with Rachael Ray, and the direct sales company, Taste of Home Entertaining, Inc. He earned both his BS and MBA from New York University, and is a certified public accountant.
Moira McCarthy Stanford
Moira McCarthy Stanford has been a vocal diabetes advocate since her youngest daughter, Lauren, was diagnosed with T1D more than 25 years ago. She has served many roles at JDRF, including National Chair of Advocacy and Chairman of the Board of the Diabetes Scholars Foundation. The author of two best-selling books on raising children with diabetes, she’s also a world-renowned travel, ski, and adventure writer. Helping IFL is a perfect match for her push for a cure. “I’m thrilled to be part of IFL’s vital mission.” Moira lives in Plymouth, Massachusetts, where—when she’s not skiing — she’s crazy about tennis, golf, the beach, and her grandchildren.
CATHERINE HUNT RYAN
Catherine Hunt Ryan is the president of Bechtel’s Manufacturing & Technology business, with responsibility for the worldwide markets of design, construction, and project delivery for semiconductors, electric vehicles, synthetic materials, and data centers. Catherine has two decades of EPC industry experience in energy, infrastructure, and water sectors. At Bechtel, she has held key project development, project management, and executive leadership roles. Before leading the Manufacturing and Technology business, Catherine was the chief financial officer of Bechtel Group, Inc., responsible for leading the finance organization, which includes Bechtel Enterprises and the corporate planning, treasury, tax, and shared service functions. Catherine joined Bechtel in 2007, initially working in Bechtel Enterprises, the company’s project development, investment, and financing services group. Catherine transitioned to Bechtel Energy in 2013 and was the project controls and commercial lead of the Sabine Pass Liquefaction project. She became the CFO of the Energy business in 2016 and became the CFO of Bechtel Group in 2018. Before joining Bechtel, Catherine worked at the World Bank’s Infrastructure Economics and Finance unit with a focus on contract design and economic regulation for private investment in power and water utilities. Catherine earned a bachelor’s degree in political science from Stanford University, and a master’s degree in public policy from Harvard Kennedy School. She is on the board of the Bechtel Group as well as educational institutions including the Stanford Construction Institute and Beauvoir School.
HENRY ANHALT
Dr. Henry Anhalt is a pediatric endocrinologist and the VP, Medical Affairs of Science37. Prior to his appointment at Science37, he was CMO of the T1D Exchange, a nonprofit organization that created a new paradigm fostering collaboration among patients, physicians, researchers and industry to speed discovery of better therapies for type 1 diabetes. He held numerous executive positions in the medical device and biopharmaceutical industries. Dr. Anhalt has held senior leadership positions in many professional organizations and currently serves as chair of the Hormone Health Network of the Endocrine Society. In addition, he serves on the Board of Directors of camp Nejeda, a camp for children with type 1 diabetes.
